Serotonin News and Research

Latest Serotonin News and Research

Environmental toxicants contribute to obesity and metabolic disease

In a recent study published in the Current Opinion in Pharmacology journal, researchers assessed the impact of environmental toxicants and brown adipose tissue (BAT) on obesity and metabolic disorders.

4 Nov 2022

Are men or women impacted more by adverse reactions to prescription drug treatments?

Recently, researchers presented an overview of sex-based differences in adverse drug reactions (ADRs) based on epidemiology, technique, and underlying mechanism data.

11 Oct 2022

New compound triggers the same anti-depressant action as rapidly acting psychedelic drugs

While illegal for recreational use, psychedelic drugs are showing great promise as treatments for severe depression and anxiety, as well as alcohol addiction and other conditions.

28 Sep 2022

JGU researchers seek to gain a better understanding of depression

Human beings and fruit flies have very little in common - at first sight. However, studying these flies it is in fact possible to find out more about human nature, particularly when it comes to depressive disorders.

16 Sep 2022

Nutritional approaches targeting gut microbiome could improve brain disorders

A new review published in the Clinical Nutrition and Metabolic Care journal focused on studies that utilized the dietary gut microbiota–target interventions to improve mental health conditions. It also discussed some suggestions for developing more robust and informative interventions for diet–microbiome studies.

15 Sep 2022

Can daytime feeding prevent mood vulnerability in night workers?

A new study explores the effect of daytime feeding on affective disorder incidence in this subset of workers.

15 Sep 2022

Researchers review role of melatonin in pregnancies complicated by placental insufficiency

A new study explores the role of melatonin in pregnancy.

8 Sep 2022

Exposure to blue light may accelerate aging

A new study provides insights into the novel mechanisms through which blue light exposure interferes with non-retinal cell metabolic pathways in flies.

5 Sep 2022

MOO can alleviate depression via increasing 5-HTP in the gut microbiota, study reveals

Announcing a new article publication from Acta Pharmaceutica Sinica B. Morinda officinalis oligosaccharides(MOO) is an oral drug approved in China for the treatment of depression in China.

5 Sep 2022

New kind of synapse discovered in neurons’ tiny hairs

Scientists at HHMI's Janelia Research Campus have discovered a new kind of synapse in the tiny hairs on the surface of neurons.

1 Sep 2022

FAU and Tel Aviv researchers receive grant to tackle Alzheimer’s-related mood disorders

Alzheimer's disease (AD) is the most common type of dementia affecting an estimated 6.3 million Americans age 65 and older. Without the development of medical breakthroughs to prevent, treat, slow or cure AD that number could grow to 13.8 million by 2060.

29 Aug 2022

Inactivation of particular protein complex associated with Parkinson's and anxiety disorders

Inactivation of a particular protein complex that plays a key role in keeping genes switched off leads to nerve cells not producing enough essential neurotransmitters.

29 Aug 2022

Scientists demonstrate safety of neurosurgical procedure used to measure dopamine and serotonin

Scientists at Wake Forest University School of Medicine have demonstrated that a neurosurgical procedure used to research and measure dopamine and serotonin in the human brain is safe.

24 Aug 2022

Case report on the post-orgasmic illness treated with antihistamines

Scientists discuss a post-orgasmic illness syndrome patient’s experience of being treated with an antihistamine.

23 Aug 2022

Study sheds light on the pathogenic brain mechanisms associated with evolution of anxiety

Monoamine neurotransmitters such as serotonin and dopamine play important roles in our cognitive and emotional functions.

5 Aug 2022

Repurposing an antipsychotic drug to treat various types of cancer

To treat some of the psychosis issues associated with Parkinson's disease, physicians often prescribe pimavanserin, an antipsychotic drug that acts within the brain to prevent hallucinations and delusions.

28 Jul 2022

Genetic variations in one serotonin receptor could be the reason behind psychedelic treatment disparity

When all else fails, some patients trying to overcome alcoholism, severe depression or anxiety, and even cluster headaches, turn to psychedelic drugs, which clinical research has shown can help treat individuals with these conditions, sometimes with dramatically positive results.

27 Jul 2022

Serotonin News and Research

Latest Serotonin News and Research

Environmental toxicants contribute to obesity and metabolic disease

Are men or women impacted more by adverse reactions to prescription drug treatments?

New compound triggers the same anti-depressant action as rapidly acting psychedelic drugs

JGU researchers seek to gain a better understanding of depression

Nutritional approaches targeting gut microbiome could improve brain disorders

Can daytime feeding prevent mood vulnerability in night workers?

Researchers review role of melatonin in pregnancies complicated by placental insufficiency

Exposure to blue light may accelerate aging

MOO can alleviate depression via increasing 5-HTP in the gut microbiota, study reveals

New kind of synapse discovered in neurons’ tiny hairs

FAU and Tel Aviv researchers receive grant to tackle Alzheimer’s-related mood disorders

Inactivation of particular protein complex associated with Parkinson's and anxiety disorders

Scientists demonstrate safety of neurosurgical procedure used to measure dopamine and serotonin

Case report on the post-orgasmic illness treated with antihistamines

Study sheds light on the pathogenic brain mechanisms associated with evolution of anxiety

Repurposing an antipsychotic drug to treat various types of cancer

Genetic variations in one serotonin receptor could be the reason behind psychedelic treatment disparity

Genetic variations in serotonin receptor causes different response to psychedelic drugs

What is the role of psychedelic drugs in the treatment of psychiatric disorders?

Review: No clear evidence that serotonin levels are responsible for depression

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Serotonin News and Research

Latest Serotonin News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in